SINGAPORE and TOKYO, Oct. 14, 2024 /PRNewswire/ — Reeracoen, Asia’s leading human resource services provider, in collaboration with Rakuten Insight Global, has released a “Perception of AI in the Workplace” report surveying over 400 professionals across 50 industries. The report examines generational perspectives on AI in professional settings. It aligns with Singapore’s recent announcement of a SG$1 billion investment plan under the Smart Nation 2.0 initiative to enhance the nation’s AI capabilities and promote responsible adoption.

Key Findings Reveal Generational Divide and Upskilling Trends

1.         AI Anxiety Across Generations

The survey reveals that while 53.5% of participants express concern about AI replacing jobs, Gen Z shows the highest levels of anxiety regarding job security. The data highlights the importance of developing robust workforce strategies to address these concerns.

2.         Proactive Upskilling Initiatives:

A remarkable 62.4% of respondents are actively preparing for an AI-driven future and remaining competitive, primarily through data analysis and AI courses. This trend aligns with government initiatives aimed at fostering an AI-savvy workforce.

3.         Corporate Support Gap:

Mixed sentiments were noted regarding corporate support for AI integration. Only 23.1% of respondents felt their companies were very supportive in preparing for AI changes, indicating a critical need for enhanced corporate strategies to foster employee readiness.

Bridging the AI Readiness Gap

Mr Kenji Naito, Group CEO of Reeracoen Group, emphasised, “As AI reshapes the workforce, our role is to guide companies and job seekers to navigate these changes successfully. This report provides invaluable insights, enabling us to align our strategies with Singapore’s Smart Nation 2.0 vision and connect businesses with AI-ready talent. Our findings show that while AI adoption is accelerating, companies must take proactive steps to support their employees’ upskilling. By connecting businesses with high-calibre candidates, we will continue contributing to Singapore’s vision of becoming a global AI hub.“

Implications for Asia’s Job Market

The “Perception of AI in the Workplace” report serves as a crucial roadmap for:

Shaping recruitment strategies in an AI-driven landscapeGuiding talent acquisition to meet evolving market demandsInforming employee training programmes to address AI skill gaps

As Singapore positions itself as a leader in AI innovation, this report offers timely insights for businesses and professionals navigating the changing job market.

To learn more about Reeracoen Singapore’s recruitment solutions and insights, please visit:

Website: https://www.reeracoen.sg/en/services/recruitment_solutions LinkedIn: https://www.linkedin.com/company/reeracoen-singapore-pte-ltd-/

About Reeracoen Group

Reeracoen is a prominent force in Asia’s recruitment landscape, recognized for its expertise in connecting top-tier talent with leading organizations. As a major player in the region, we leverage our expansive networks and deep industry insights to deliver exceptional recruitment solutions that meet the evolving needs of our partners. Backed by the strength and reputation of the Neo-career Group, we uphold the same standards of Japanese professionalism and service excellence across our nine offices in six major Asian countries. This allows us to provide unparalleled service quality and cross-border talent solutions, making us the preferred recruitment partner for businesses looking to thrive in the dynamic Asian market. For more information, visit https://www.reeracoen.sg/ and follow us on social media for the latest updates and insights.

About Rakuten Insight Global, Inc. 

Rakuten Insight Global, Inc. (“Rakuten Insight”) is a wholly-owned online market research subsidiary of Rakuten Group, Inc., a global leader in internet services, headquartered in Tokyo. Rakuten Insight was established in 1997 as AIP Corporation and became part of the Rakuten Group in 2014. Rakuten Insight possesses a research panel focusing on 12 major Asian markets & the US and a panel network covering 60 countries and regions. With offices in 11 countries and regions, Rakuten Insight provides market research for over 500 leading companies around the world. Rakuten Insight Singapore serves as an off-shore market research hub to drive business development and provide multi-lingual and multi-functional operational support for clients based across Southeast Asia. For more information, visit https://insight.rakuten.com/ and follow us on social media.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/reeracoen-unveils-ai-in-the-workplace-report-aligning-with-singapores-smart-nation-2-0-initiative-302272874.html

SOURCE Reeracoen Singapore Pte Ltd

TEL AVIV, Israel, Oct. 14, 2024 /PRNewswire/ — Symmetrium, the zero-trust, mobile data governance, and security platform designed to turn any mobile device into a virtual extension of the enterprise, inheriting all its compliance, security and IT protocols, is excited to announce the launch of the new Symmetrium Partner Program. The new program is open to all channel partners, including resellers, distributors and MSPs.

Through this program, Symmetrium provides a comprehensive suite of resources to deliver a robust zero-trust mobile security framework to protect the data of their customers and empower its partners to increase their business outcomes.

“Symmetrium believes that partners are a core component of our business success, enabling us to reach more customers and meet the global demand for our innovative corporate zero-trust mobile security solution,” said Omer Cohen, founder and CEO of Symmetrium. “With mobile security a key vulnerability for corporate networks in the era of hybrid working, we look forward to collaborating with our partners worldwide to help solve the threats businesses face from remote access to their networks. We look forward to expanding our partner ecosystem and helping our partners deliver stellar services and customer experiences.”

Symmetrium Partners are eligible for a suite of additional benefits in the areas of sales, marketing and support, including a deal registration program, lead sharing, a dedicated marketing manager, marketing resources and a comprehensive enablement plan.

The new program offers partners access to Symmetrium’s fully managed support services, designed to reduce the resources required by partners, allowing them to focus on delivering exceptional customer experiences.

For more information and to sign up for Symmetrium’s partner visit https://symmetrium.io/partners.

About Symmetrium

Symmetrium is a zero-trust, mobile data governance and security platform designed to turn any mobile device into a virtual extension of the enterprise, inheriting all its compliance, security and IT protocols. Symmetrium keeps no data at risk by allowing no data at rest, all while delivering users a completely native mobile access solution that can be quickly and easily deployed.

Media Contact:
Roni Dagan
roni@symmetrium.io

View original content:https://www.prnewswire.co.uk/news-releases/symmetrium-introduces-new-partner-program-to-enhance-resell-opportunities-302274553.html

News Summary:

Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders.Novel digestion enzymes deliver complete RNA sequence coveragei for more confident characterization, while new LC-MS-grade reagents increase sensitivity and improve detection accuracy of RNA components.iiNew waters_connect™ MAP Sequence software accelerates RNA oligonucleotide mapping using semi-automated workflows that reduce data processing time over manual techniques, enabling routine monitoring of key product attributes.

MILFORD, Mass., Oct. 14, 2024 /PRNewswire/ — Waters Corporation (NYSE: WAT) today introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LC-MS) analysis. When used together in a workflow, these bioseparations tools help accelerate and improve the development of innovative large molecule RNA-based pharmaceuticals, such as CRISPR sgRNA and mRNA therapeutics.

Large molecule RNA (ribonucleic acid) therapeutics represent some of the most exciting and potentially life-saving developments in pharmaceuticals today. They include new and more effective vaccines for diseases like COVID-19, personalized cancer treatments, as well as emerging CRISPR RNA therapies that address challenging genetic conditions, such as sickle cell anemia.

“As RNA-based therapies are prepared for widespread use, more direct composition measurements are needed to ensure stability, safety, and effectiveness for patients,” said Erin Chambers, Vice President, Consumables and Lab Automation at Waters Corporation. “The combination of Waters enzymes, reagents, and software are specially designed to simplify the confirmation of sequence and modifications of complex molecules. These analytical tools can accelerate RNA therapeutic development and lower barriers for use by LC-MS non-experts.”

“As innovators looking to help our customers advance nucleic acid-based therapies and reduce the burden of serious diseases, we are always seeking new technologies to improve characterization and accelerate development,” said Arnaud Delobel, PhD, R&D and Innovation Director at Quality Assistance S.A. and beta tester of the Waters RNA analytical tools. “Waters new enzymes efficiently digest mRNA and sgRNA with short incubation times and data processing in MAP Sequence allows the user to obtain reproducible results quickly with confidence.”

The Waters RNA analytical tools include:

Enzymes: Two novel enzymes, RapiZyme™ MC1 and RapiZyme Cusativin, are used in a simplified three-step protocol that provides complete LC-MS sequence coverage over traditional digestion methods enabling more confident characterization of RNA molecules.iiiReagents: IonHance™ HFIP, an LC-MS-grade reagent, is formulated to improve ionization and delivers increased spectral clarity and detection accuracy of RNA components.Software: New MAP Sequence application on the waters_connect software platform simplifies RNA LC-MS oligo mapping workflows to accelerate analysis and data processing time over manual techniques using spreadsheets.

Used together within a workflow, the tools generate an LC-MS fingerprint to confirm product identity, purity, and efficacy. The tools improve sequence coverage, LC-MS spectral data quality, and data interpretation. Supported by the compliance-ready waters_connect software platform, these tools help transition LC and LC-MS-based digestion analysis from discovery and development to release and at-line process analytical testing.

Waters RapiZyme RNAses and IonHance HFIP are now available. The new MAP Sequence App on waters_connect software will be available on October 18, 2024.

Additional Resources

Learn more about the Waters RNA Analytical ToolsListen to our webinar “Cracking the Code: Analyzing mRNA and sgRNA with Advanced Enzymes, Mass Spectrometry, and Informatics on Oct. 16 at 11:00am ETJoin Waters at the PharmSci 360 conference for an expert session on “Oligo Mapping of Large RNA Therapeutics by Novel Enzyme Specificities” with Dr. Bala Addepalli, Waters Director, R&D New Modalities Portfolio on Oct. 21, at 11:00am ETFollow and connect with Waters via LinkedIn, Twitter, and Facebook

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,500 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.

Waters, Rapizyme, IonHance, and waters_connect are trademarks of Waters Technologies Corporation.

Contact:
Janice Foley
Senior Public Relations Manager, Corporate Communications
Waters Corporation
janice_foley@waters.com
+1.617.823.5555

i 100% RNA sequence coverage achieved for HPRT sgRNA digested with RapiZyme MC1 and RapiZyme Cusativin compared to traditional digestion methods such as RNase T1. Waters Application Note 720008539EN: “Tunable Digestions of RNA Using RapiZyme RNases to Confirm Sequence and Map Modifications” .

ii IonHance HFIP reagents are certified to contain less than 100 ppb sodium and less than 100 ppb potassium content, resulting in reduced adduct formation and improved sensitivity of RNA detection compared to commercially available HFIP. Waters Application Note 720008540EN: “Evaluating IonHance Hexafluoroisopropanol (HFIP) for Enhanced LC-MS Oligonucleotide Analysis”

iii Waters RapiZyme RNase protocol simplifies sample preparation with three steps including reagent preparation, RNA digestion, and heat inactivation without the need to add chemical denaturants and enzyme inhibitors.